Story perspectives

FDA Approves Wegovy Oral Pill to Combat Obesity Crisis

12/23/2025

Center

FDA Approves Wegovy

The U.S. Food and Drug Administration approved Novo Nordisk's Wegovy oral weight-loss pill on December 22, 2025.
The approval aims to expand access to weight-loss treatments amid rising obesity, with 40% of American adults obese.
Analysts predict oral medications could capture a significant market share by 2030.
Amanda Bynes shared her weight loss journey on Instagram, reporting nearly 30 pounds lost using Ozempic.

Right

Restaurants Adapt Menus

In New York City, restaurants are adapting to glucagon-like peptide-1 (GLP-1) medications like Ozempic that suppress appetite.
Clinton Hall, a New York City restaurant, introduced a Teeny Weeny Mini Meal with smaller portions and lower prices.
Chipotle Mexican Grill, the restaurant chain, launched a High Protein Menu that includes GLP-1 friendly options.
Experts say these medications aid weight loss, but their long-term effects on eating culture remain uncertain.

1 of 2

FDA Approves Wegovy

The U.S. Food and Drug Administration approved Novo Nordisk's Wegovy oral weight-loss pill on December 22, 2025.
The approval aims to expand access to weight-loss treatments amid rising obesity, with 40% of American adults obese.
Analysts predict oral medications could capture a significant market share by 2030.
Amanda Bynes shared her weight loss journey on Instagram, reporting nearly 30 pounds lost using Ozempic.

1 / 2